In our model system, ectopic expression of CD74 was sufficient to rescue the immune and clinical phenotypes detected in IRF8-mutant B cell lymphomas, but it did not significantly change the immune landscape or growth pattern of IRF8 WT B cell lymphomas. This evidence concerns the gene CD74 and B-cell non-Hodgkin lymphoma.